XML 46 R33.htm IDEA: XBRL DOCUMENT v3.7.0.1
EARNINGS PER SHARE (Tables)
6 Months Ended
Jun. 30, 2017
EARNINGS PER SHARE [Abstract]  
Common shares excluded from calculating basic and diluted net loss per common share
Shares used in calculating basic and diluted net loss per common share exclude these potential common shares as of June 30, 2017 and December 31, 2016:

   
June 30, 2017
  
December 31, 2016
 
Warrants to purchase Common Stock
  83,234,617   26,179,560 
Stock options to purchase Common Stock
  227,403   691,237 
Common stock issuable upon the assumed conversion of  our convertible promissory notes (1)
  31,250,000   --- 
Common stock issuable upon the assumed conversion of  our Series B preferred stock (2)
  125,000,000   --- 
  Total
  239,712,020   26,870,797 

(1)
As part of the Initial Note and the Second Note, at the holder’s option, all unpaid principle and interest due under each convertible promissory note may be converted into shares of Common Stock based on a conversion price of $0.04 per share.  The Initial Note and the Second Note matures on February 27, 2019 and March 31, 2019, respectively, and on each maturity date each convertible promissory note, and accrued interest thereon, is subject to mandatory conversion based on a conversion price of $0.04 per share.  For the purposes of this Table, we have assumed that all outstanding principal and interest will be converted on each applicable maturity date.
(2)
Pursuant to the March 2017 Offering, Velo LLC purchased 1,250 shares of Series B Convertible Preferred Stock of the Company for $5,000,000.  The Series B Convertible Preferred Stock that was issued in the March 2017 Offering, (a) voted together with the Common Stock as a single class (subject to standard protective provisions for the Series B Convertible Preferred Stock), (b) had the same dividend rights as the Common Stock, (c) had a liquidation preference equal to the greater of its purchase price and its as converted-to-Common Stock value, (d) automatically converted into Common Stock when the number of authorized shares of Common Stock was increased within 190 days of the second closing as necessary to permit all outstanding convertible or exercisable securities (including the Series B Convertible Preferred Stock) to convert to Common Stock, and (e) was convertible into Common Stock  at the discretion of the holder, subject to the availability of authorized shares, at an as-converted-to-Common Stock purchase price of $0.04 per share.   On August 1, 2017, all 1,250 outstanding shares of Series B Convertible Preferred Stock converted into 125,000,000 shares of Common Stock as a result of the approval by the stockholders at the 2017 Annual Meeting of Stockholders held on July 25, 2017, and the filing in July 2017, of an amendment increasing our authorized shares of Common Stock to 750,000,000 shares.